Zevra Therapeutics, Inc.
ZVRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1 | $75 | -$3 | -$36 |
| Dep. & Amort. | $0 | $2 | $2 | $2 |
| Deferred Tax | -$0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $4 |
| Change in WC | -$2 | -$7 | -$7 | $2 |
| Other Non-Cash | $5 | -$75 | -$3 | $12 |
| Operating Cash Flow | $5 | -$4 | -$8 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$65 | -$150 | -$7 | -$15 |
| Inv. Sales/Matur. | $211 | $13 | $18 | $0 |
| Other Inv. Act. | -$149 | $150 | $0 | $9 |
| Investing Cash Flow | -$5 | $12 | $11 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | -$16 |
| Stock Issued | $0 | $1 | $2 | -$66 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $0 | $0 | $83 |
| Financing Cash Flow | $7 | $1 | $2 | $1 |
| Forex Effect | $0 | $1 | -$0 | $1 |
| Net Chg. in Cash | $7 | $10 | $4 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48 | $37 | $34 | $54 |
| End Cash | $54 | $48 | $37 | $34 |
| Free Cash Flow | $4 | -$4 | -$8 | -$16 |